JP2024112817A5 - - Google Patents
Info
- Publication number
- JP2024112817A5 JP2024112817A5 JP2024074339A JP2024074339A JP2024112817A5 JP 2024112817 A5 JP2024112817 A5 JP 2024112817A5 JP 2024074339 A JP2024074339 A JP 2024074339A JP 2024074339 A JP2024074339 A JP 2024074339A JP 2024112817 A5 JP2024112817 A5 JP 2024112817A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021141253 | 2021-08-31 | ||
| JP2021141253 | 2021-08-31 | ||
| JP2022068967 | 2022-04-19 | ||
| JP2022068967 | 2022-04-19 | ||
| JP2022136673A JP7483810B2 (ja) | 2021-08-31 | 2022-08-30 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022136673A Division JP7483810B2 (ja) | 2021-08-31 | 2022-08-30 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024112817A JP2024112817A (ja) | 2024-08-21 |
| JP2024112817A5 true JP2024112817A5 (https=) | 2025-09-08 |
Family
ID=85411220
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022136673A Active JP7483810B2 (ja) | 2021-08-31 | 2022-08-30 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
| JP2024074339A Withdrawn JP2024112817A (ja) | 2021-08-31 | 2024-05-01 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022136673A Active JP7483810B2 (ja) | 2021-08-31 | 2022-08-30 | ６－アミノピラゾロピリミジン化合物及びその医薬用途 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20240287079A1 (https=) |
| EP (1) | EP4397663A4 (https=) |
| JP (2) | JP7483810B2 (https=) |
| KR (1) | KR20240055035A (https=) |
| AR (1) | AR126912A1 (https=) |
| AU (1) | AU2022340126A1 (https=) |
| CA (1) | CA3229401A1 (https=) |
| CL (1) | CL2024000581A1 (https=) |
| CO (1) | CO2024002515A2 (https=) |
| IL (1) | IL310062A (https=) |
| MX (1) | MX2024002609A (https=) |
| PE (1) | PE20240882A1 (https=) |
| TW (1) | TW202328134A (https=) |
| WO (1) | WO2023032987A1 (https=) |
| ZA (1) | ZA202400656B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250114361A1 (en) * | 2022-08-29 | 2025-04-10 | Japan Tobacco Inc. | Pyrazolopyrimidine compound and pharmaceutical use thereof |
| IL322520A (en) * | 2023-02-24 | 2025-10-01 | Japan Tobacco Inc | Modified pyrazolopyrimidine compounds and their medical use |
| JP7729000B2 (ja) * | 2023-02-24 | 2025-08-25 | 日本たばこ産業株式会社 | ６－アルコキシピラゾロピリミジン化合物及びその医薬用途 |
| KR20250170647A (ko) | 2023-04-14 | 2025-12-05 | 다케다 야쿠힌 고교 가부시키가이샤 | Nlrp3 억제제로서의 피라졸로피리미딘 유도체 |
| KR20260027946A (ko) | 2023-06-02 | 2026-03-03 | 머크 샤프 앤드 돔 엘엘씨 | Nod-유사 수용체 단백질 3의 억제제로서 유용한 5,6 불포화 비시클릭 헤테로사이클 |
| US20250195511A1 (en) * | 2023-12-14 | 2025-06-19 | Merck Sharp & Dohme Llc | Indazole derivatives useful as inhibitors of nod-like receptor protein 3 |
| TW202532066A (zh) * | 2023-12-14 | 2025-08-16 | 美商默沙東有限責任公司 | 作為nod樣受體蛋白3抑制劑之氮雜吲唑衍生物 |
| WO2025140708A1 (zh) * | 2023-12-31 | 2025-07-03 | 杭州百新生物医药科技有限公司 | 吡唑并嘧啶类化合物及其医药用途 |
| WO2025153532A1 (en) | 2024-01-16 | 2025-07-24 | NodThera Limited | Nlrp3 inhibitors and glp-1 agonists combination therapies |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2013007253A0 (en) * | 2011-04-21 | 2013-11-30 | Origenis Gmbh | Pyrazolo [4,3-D] pyrimidines useful as kinase inhibitors |
| WO2017205766A1 (en) * | 2016-05-27 | 2017-11-30 | Pharmacyclics Llc | Inhibitors of interleukin-1 receptor-associated kinase |
| WO2020150114A1 (en) * | 2019-01-14 | 2020-07-23 | Innate Tumor Immunity, Inc. | Heterocyclic nlrp3 modulators, for use in the treatment of cancer |
| US12391675B2 (en) * | 2019-01-14 | 2025-08-19 | Innate Tumor Immunity, Inc. | NLRP3 modulators |
-
2022
- 2022-08-30 CA CA3229401A patent/CA3229401A1/en active Pending
- 2022-08-30 US US18/566,623 patent/US20240287079A1/en active Pending
- 2022-08-30 TW TW111132739A patent/TW202328134A/zh unknown
- 2022-08-30 PE PE2024000332A patent/PE20240882A1/es unknown
- 2022-08-30 AU AU2022340126A patent/AU2022340126A1/en active Pending
- 2022-08-30 WO PCT/JP2022/032606 patent/WO2023032987A1/ja not_active Ceased
- 2022-08-30 KR KR1020247010356A patent/KR20240055035A/ko active Pending
- 2022-08-30 AR ARP220102331A patent/AR126912A1/es unknown
- 2022-08-30 EP EP22864569.3A patent/EP4397663A4/en active Pending
- 2022-08-30 IL IL310062A patent/IL310062A/en unknown
- 2022-08-30 MX MX2024002609A patent/MX2024002609A/es unknown
- 2022-08-30 JP JP2022136673A patent/JP7483810B2/ja active Active
-
2024
- 2024-01-18 ZA ZA2024/00656A patent/ZA202400656B/en unknown
- 2024-02-26 CL CL2024000581A patent/CL2024000581A1/es unknown
- 2024-02-28 CO CONC2024/0002515A patent/CO2024002515A2/es unknown
- 2024-05-01 JP JP2024074339A patent/JP2024112817A/ja not_active Withdrawn